| Roche Pharma (Schweiz) AG - Herceptin subkutan 600mg/5ml, Lösung zur subkutanen Injektion |
| 65964 | | 01 | | Herceptin subkutan 600mg/5ml | | Lösung zur subkutanen Injektion | | Codice | | | | 24.11.2016 | | |
|
| Composition |
| trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, methioninum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Lösung zur subkutanen Injektion | | | | | | | | Active Agent | Dose |
|---|
| Trastuzumab | 600mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Trastuzumab | 600 mg |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Methionine | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 1484.04 | 1630.40 | A | SL | No |
|
